Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Charlevoix-SaguenayÀÇ »ó¿°»öü¿­¼º°­Á÷½ÇÁ¶ Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay

´ëÇѽŰæ°úÇÐȸÁö 2019³â 37±Ç 1È£ p.69 ~ 72
ºÀÁ¤ºó, ±è½Â¿ì, À̽ÂÅÂ, ÃÖÁ¾¶ô, ½ÅÇÏ¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
ºÀÁ¤ºó ( Bong Jeong-Bin ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç

±è½Â¿ì ( Kim Seung-Woo ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
À̽ÂÅ ( Lee Seung-Tae ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
ÃÖÁ¾¶ô ( Choi Jong-Rak ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
½ÅÇÏ¿µ ( Shin Ha-Young ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç

Abstract


Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), which is caused by mutations in SACS gene, is a very rare neurodegenerative disorder characterized by the clinical triad of early onset cerebellar ataxia, pyramidal tract features, and sensorimotor polyneuropathy. Herein, we report a 35-year-old Korean male who presented with gait disturbance and lower extremity weakness. Neuroimaging and ophthalmologic evaluation revealed features consistent with ARSACS. Mutation in SACS gene was demonstrated in clinical exome sequence analysis and the patient was finally diagnosed as ARSACS.

Å°¿öµå

Spastic ataxia Charlevoix-Saguenay type; Cerebellar Ataxia; SACS gene

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS